Dehydroepiandrosterone Sulphate
Introduction
Dehydroepiandrosterone sulphate (DHEAS) is the most abundant circulating steroid hormone in the human body. Primarily synthesized by the adrenal glands, with minor contributions from the gonads and brain, its levels naturally peak in early adulthood and progressively decline with age. It is recognized as a significant endocrine-related trait in various health studies. [1]
Biological Basis
DHEAS is the sulfated form of dehydroepiandrosterone (DHEA), an endogenous steroid hormone. It functions as a crucial precursor in the biosynthesis of both androgens (male sex hormones) and estrogens (female sex hormones). DHEAS acts as a metabolic reservoir, allowing the body to convert it into more potent steroid hormones in various peripheral tissues as needed, thereby playing a fundamental role in the body's overall steroidogenesis pathway.
Clinical Relevance
Due to its widespread presence and precursor role, DHEAS levels are frequently assessed in both clinical diagnostics and research. Concentrations of DHEAS are typically measured on serum samples, often using techniques such as radioimmunoassay. [1] Its levels are analyzed in large-scale genetic investigations, such as genome-wide association studies within the Framingham Heart Study, to elucidate genetic influences on endocrine traits and their associations with various health outcomes. [1] Deviations from normal DHEAS levels can serve as indicators for certain endocrine conditions, including disorders of the adrenal glands or pituitary function.
Social Importance
DHEAS has attracted considerable public attention, particularly as a dietary supplement marketed with claims related to anti-aging, energy enhancement, and cognitive improvement. However, the scientific community emphasizes the complex nature of its biological functions and advises caution regarding supplementation without medical oversight. Ongoing research continues to explore the genetic and environmental factors that influence DHEAS levels and their broader implications for human health and longevity.
Methodological and Statistical Constraints
Research into dehydroepiandrosterone sulphate often faces limitations related to the scope and power of genetic analyses. Early genome-wide association studies (GWAS) frequently utilized genotyping platforms with a limited number of single nucleotide polymorphisms (SNPs), such as the 100K Affymetrix GeneChip or subsets of HapMap SNPs, which inherently restricts the coverage of genomic variation These genes play a significant role in the liver and other tissues, influencing the overall hormonal milieu. [2]
A substantial group of variants are found within or near zinc finger protein (ZNF) genes, including ZNF789, ZNF394, ZNF655, and ZKSCAN5, with associated single nucleotide polymorphisms (SNPs) like rs148982377, rs111390579, rs10278040, and rs34670419. Zinc finger proteins are a large family of transcription factors that regulate gene expression by binding to DNA, RNA, or proteins. Variations in these genes could alter the regulatory networks controlling steroidogenesis, DHEA-S production, or the sensitivity of target tissues to steroid hormones. The impact of such genetic changes on gene expression can lead to subtle yet significant shifts in metabolic pathways, potentially influencing DHEA-S levels. [2] The FAM200A and TMEM225B genes, sometimes found in proximity to these zinc finger proteins, may also contribute to these regulatory effects, though their precise roles in DHEA-S metabolism are still under investigation.
Other variants affect genes involved in diverse cellular functions, which can indirectly relate to DHEA-S. The rs77356530 variant in the ATP5MF-PTCD1 and PTCD1 region is noteworthy; ATP5MF is a component of mitochondrial ATP synthase, critical for cellular energy production, while PTCD1 is involved in mitochondrial RNA processing. Mitochondrial function is essential for steroid synthesis, and variations affecting these processes could therefore impact DHEA-S levels. Similarly, variants rs615567, rs955783, and rs67836407 in the FGF9 gene, which encodes Fibroblast Growth Factor 9, could influence endocrine signaling pathways that regulate hormone production and activity. The PUDP gene, with variants rs5979866 and rs5935876, is thought to be involved in lipid and sterol metabolism, pathways intimately linked to steroid hormone synthesis. [2] Lastly, the rs143524414 variant in the ARPC1A - ARPC1B region affects genes encoding components of the Arp2/3 complex, which is crucial for actin cytoskeleton organization and cell motility. While seemingly distant, cellular structural integrity and signaling are fundamental to the proper functioning of endocrine cells, and such variants might subtly influence their capacity for DHEA-S synthesis or secretion.
Nature and Significance of Dehydroepiandrosterone Sulphate (DHEAS)
Dehydroepiandrosterone sulphate (DHEAS) is precisely defined as a sulfated steroid hormone and a key endocrine-related trait, making its quantitative measurement a valuable biomarker in both clinical and research contexts. Its levels in serum are routinely assessed to provide insights into an individual's endocrine status and potential associations with various physiological conditions. [1] As a biomarker, DHEAS plays a significant role in understanding underlying biological processes and identifying potential disease risks, particularly within the complex interplay of the endocrine system. [2] The inclusion of DHEAS in large-scale genome-wide association studies underscores its importance in elucidating genetic factors that influence hormone regulation and overall endocrine function. [1]
Measurement and Operational Definitions
The operational definition of dehydroepiandrosterone sulphate (DHEAS) levels in research studies is established through rigorous measurement protocols and subsequent statistical adjustments. Serum DHEAS concentrations are typically determined using a radioimmunoassay method. [1] To ensure consistency and reduce variability, blood samples for DHEAS analysis are usually collected after an overnight fast, with collection times standardized to the morning hours, specifically between 0800 and 1100 hours. [3]
In analytical frameworks, DHEAS phenotypes are often represented as normalized residuals, a statistical approach used to account for potential confounding variables. These residuals are initially adjusted for demographic factors such as age and sex, and further refined through comprehensive multivariable adjustments. [1] The multivariable adjustment models for DHEAS incorporate a broad array of covariates, including age, sex, diabetes mellitus, impaired fasting glucose, smoking status, systolic blood pressure, diastolic blood pressure, body mass index, hypertension treatment, prevalent cardiovascular disease, total cholesterol/HDL ratio, and alcohol intake, thereby allowing for a more isolated examination of DHEAS associations. [1]
Contextual Classification and Related Traits
Dehydroepiandrosterone sulphate is classified as an integral endocrine-related trait, frequently analyzed alongside other hormonal biomarkers such as thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) to offer a comprehensive view of endocrine system functionality. [1] Its designation as a "biomarker trait" highlights its utility as an indicator of physiological states and potential disease susceptibility, distinguishing it from direct clinical disease endpoints. [2] While the provided context does not detail specific disease classifications or severity gradations directly tied to DHEAS levels, its measurement is fundamental to research aimed at uncovering genetic predispositions and metabolic pathways related to complex health traits. [1]
DHEAS as a Steroid Hormone and Endocrine Biomarker
Dehydroepiandrosterone sulphate (DHEAS) is a vital steroid hormone found in the human body. [1] As a key biomolecule, it is primarily produced by the adrenal glands and serves as a precursor in the synthesis of other important hormones, including androgens and estrogens. [4] Its presence in circulation makes it a significant endocrine-related trait, reflecting overall adrenal function and steroidogenic activity. [1] Concentrations of DHEAS in serum are routinely measured using techniques like radioimmunoassay, providing a quantitative indicator of endocrine status. [1]
Metabolic Role and Systemic Physiological Impact
The biological significance of DHEAS extends to its role in various metabolic pathways that influence systemic health. [4] As a sulfated steroid, DHEAS circulates at high levels and can be converted into biologically active sex hormones such as estradiol, particularly in peripheral tissues. [4] This metabolic conversion is crucial for maintaining hormonal balance, and disruptions can lead to pathophysiological processes such as hypogonadism, which has been associated with altered estradiol levels. [4] Consequently, DHEAS plays an indirect but important role in maintaining diverse physiological functions, including bone mineral density, where its contribution to the pool of sex hormones is critical. [4]
Genetic Influences on DHEAS Levels
The levels of DHEAS in an individual are subject to genetic regulation, making it a trait of interest in genetic studies. [1] Genome-wide association studies (GWAS) investigate the genetic mechanisms underlying variation in endocrine-related traits like DHEAS, identifying genetic variants that may influence its synthesis, metabolism, or regulation. [1] These studies aim to uncover specific gene functions or regulatory elements that contribute to the observed DHEAS concentrations, thereby shedding light on the inherited components of endocrine health. [1] Understanding these genetic influences can provide insights into individual differences in hormone profiles and their potential susceptibility to related health conditions. [1]
Assessment in Endocrine Health
Dehydroepiandrosterone sulfate (DHEAS) is recognized as a significant endocrine-related trait, and its accurate measurement is crucial for evaluating an individual's hormonal status. Concentrations of DHEAS in serum samples are reliably determined using established techniques such as radioimmunoassay. [1] This enables clinicians and researchers to gain insights into adrenal function and overall androgenic activity, which are vital components of comprehensive endocrine assessment and have implications for patient care.
Biomarker in Population Health Studies
Beyond individual clinical assessment, DHEAS serves as a valuable biomarker in extensive population-based research, such as the Framingham Heart Study . [1], [2] The inclusion of DHEAS in genome-wide association studies (GWAS) focused on endocrine-related traits highlights its potential for uncovering genetic determinants that influence hormonal balance. [1] Such research contributes to a broader understanding of how DHEAS levels may be linked to various health outcomes, paving the way for future risk stratification and personalized medicine approaches.
Factors Influencing Interpretation
The clinical interpretation of DHEAS levels necessitates careful consideration of various demographic and lifestyle factors. Studies evaluating endocrine traits, including DHEAS, often adjust for variables such as age, smoking status, body-mass index, hormone-therapy use, and menopausal status to ensure accurate assessment of underlying biological associations. [5] This contextual approach is essential for distinguishing physiological variations from clinically significant alterations, thereby refining its diagnostic utility and informing personalized patient care strategies.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs11568826 rs45446698 |
CYP3A7 - CYP3A4 | etiocholanolone glucuronide measurement 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement androstenediol (3beta,17beta) monosulfate (1) measurement glyco-beta-muricholate measurement dehydroepiandrosterone sulphate measurement |
| rs148982377 | ZNF789, ZNF394 | dehydroepiandrosterone sulphate measurement hormone measurement, progesterone amount hormone measurement, testosterone measurement 16a-hydroxy DHEA 3-sulfate measurement tauro-beta-muricholate measurement |
| rs77356530 | ATP5MF-PTCD1, PTCD1 | dehydroepiandrosterone sulphate measurement educational attainment |
| rs111390579 | ZNF655 | dehydroepiandrosterone sulphate measurement |
| rs10278040 | ZKSCAN5 - FAM200A | dehydroepiandrosterone sulphate measurement X-21410 measurement androsterone sulfate measurement 5alpha-androstan-3beta,17beta-diol disulfate measurement |
| rs615567 rs955783 rs67836407 |
FGF9 - RN7SL766P | dehydroepiandrosterone sulphate measurement systolic blood pressure |
| rs5979866 rs5935876 |
PUDP | X-24546 measurement pregnenediol sulfate (C21H34O5S) measurement pregnenediol disulfate (C21H34O8S2) measurement androstenediol (3beta,17beta) monosulfate (1) measurement dehydroepiandrosterone sulphate measurement |
| rs143524414 | ARPC1A - ARPC1B | dehydroepiandrosterone sulphate measurement Calcium channel blocker use measurement Agents acting on the renin-angiotensin system use measurement |
| rs10257273 | ZNF655 - TMEM225B | dehydroepiandrosterone sulphate measurement daytime rest measurement |
| rs34670419 | ZKSCAN5 | bone tissue density hormone measurement, progesterone amount dehydroepiandrosterone sulphate measurement hormone measurement, testosterone measurement femoral neck bone mineral density |
References
[1] Hwang SJ, et al. "A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study." BMC Med Genet, 2007, 8(Suppl 1):S10.
[2] Benjamin, E. J., et al. "Genome-Wide Association with Select Biomarker Traits in the Framingham Heart Study." BMC Medical Genetics, 2007, 8(Suppl 1):S11.
[3] Sabatti, C., et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nat Genet, vol. 40, no. 12, 2008, pp. 1396-1402.
[4] Amin S, et al. "Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study." Ann Intern Med, 2000, 133:951-963.
[5] Ridker, P. M., et al. "Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study." Am J Hum Genet, vol. 82, no. 5, 2008, pp. 1185-1192.